Alan L Rotman
Examiner (ID: 15220)
Most Active Art Unit | 1201 |
Art Unit(s) | 1802, 1612, 1201, 1203, 2899, 1625 |
Total Applications | 2275 |
Issued Applications | 1794 |
Pending Applications | 68 |
Abandoned Applications | 413 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 19368315
[patent_doc_number] => 12060385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Compounds for RNA capping and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/217783
[patent_app_country] => US
[patent_app_date] => 2023-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26361
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18217783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/217783 | Compounds for RNA capping and uses thereof | Jul 2, 2023 | Issued |
Array
(
[id] => 18692711
[patent_doc_number] => 20230323041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS
[patent_app_type] => utility
[patent_app_number] => 18/208527
[patent_app_country] => US
[patent_app_date] => 2023-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208527
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208527 | Method for preparing acylated crosslinked glycosaminoglycans | Jun 11, 2023 | Issued |
Array
(
[id] => 18595935
[patent_doc_number] => 20230270725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => TREATMENT OF A BACTERIAL VAGINAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/313671
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313671
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313671 | TREATMENT OF A BACTERIAL VAGINAL INFECTION | May 7, 2023 | Pending |
Array
(
[id] => 18628180
[patent_doc_number] => 20230287028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/308842
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/308842 | C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS | Apr 27, 2023 | Pending |
Array
(
[id] => 18752515
[patent_doc_number] => 20230355775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, PREPARATION METHOD, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/301845
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301845
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301845 | NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, PREPARATION METHOD, AND USE THEREOF | Apr 16, 2023 | Pending |
Array
(
[id] => 18565668
[patent_doc_number] => 20230255995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Nicotinyl Riboside Compounds and Their Uses
[patent_app_type] => utility
[patent_app_number] => 18/135609
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135609
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135609 | Nicotinyl Riboside Compounds and Their Uses | Apr 16, 2023 | Pending |
Array
(
[id] => 18537581
[patent_doc_number] => 20230242680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MALTODEXTRIN AND PROCESS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 18/299303
[patent_app_country] => US
[patent_app_date] => 2023-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18299303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/299303 | MALTODEXTRIN AND PROCESS OF MAKING SAME | Apr 11, 2023 | Pending |
Array
(
[id] => 18921275
[patent_doc_number] => 20240024279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/131727
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131727
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131727 | METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF | Apr 5, 2023 | Pending |
Array
(
[id] => 18522947
[patent_doc_number] => 20230233597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => DIAGNOSTIC DRUG, DIAGNOSTIC METHOD AND DIAGNOSTIC DEVICE FOR PERMEABILITY OF INTESTINAL MUCOSA
[patent_app_type] => utility
[patent_app_number] => 18/131192
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131192 | DIAGNOSTIC DRUG, DIAGNOSTIC METHOD AND DIAGNOSTIC DEVICE FOR PERMEABILITY OF INTESTINAL MUCOSA | Apr 4, 2023 | Pending |
Array
(
[id] => 18649619
[patent_doc_number] => 20230295437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SILICON CONTAINING DETECTABLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/130212
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130212
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130212 | SILICON CONTAINING DETECTABLE COMPOUNDS | Apr 2, 2023 | Pending |
Array
(
[id] => 18753949
[patent_doc_number] => 20230357300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 18/188101
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188101
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188101 | TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS | Mar 21, 2023 | Pending |
Array
(
[id] => 18690956
[patent_doc_number] => 20230321129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE
[patent_app_type] => utility
[patent_app_number] => 18/181467
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181467
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181467 | METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE | Mar 8, 2023 | Pending |
Array
(
[id] => 18497478
[patent_doc_number] => 20230220119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Nanofibrillated Cellulose Fibers
[patent_app_type] => utility
[patent_app_number] => 18/180900
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180900
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180900 | Nanofibrillated Cellulose Fibers | Mar 8, 2023 | Pending |
Array
(
[id] => 18376328
[patent_doc_number] => 20230151411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => SELECTIVELY CONTROLLABLE CLEAVABLE LINKERS
[patent_app_type] => utility
[patent_app_number] => 18/156511
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156511
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/156511 | SELECTIVELY CONTROLLABLE CLEAVABLE LINKERS | Jan 18, 2023 | Pending |
Array
(
[id] => 18497714
[patent_doc_number] => 20230220393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
[patent_app_type] => utility
[patent_app_number] => 18/155730
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155730
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155730 | METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT | Jan 16, 2023 | Pending |
Array
(
[id] => 18352520
[patent_doc_number] => 20230140631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/086830
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086830
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086830 | TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS | Dec 21, 2022 | Pending |
Array
(
[id] => 18285994
[patent_doc_number] => 20230101466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD FOR PRODUCING A POLYPHENOLIC COMPOSITION FROM BARLEY MALT
[patent_app_type] => utility
[patent_app_number] => 18/062105
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062105
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062105 | METHOD FOR PRODUCING A POLYPHENOLIC COMPOSITION FROM BARLEY MALT | Dec 5, 2022 | Pending |
Array
(
[id] => 18567081
[patent_doc_number] => 20230257410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => PHENOTHIAZINE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/056008
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056008 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | Nov 15, 2022 | Pending |
Array
(
[id] => 18239067
[patent_doc_number] => 20230071378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => OLIGONUCLEOTIDE SYNTHESIZER
[patent_app_type] => utility
[patent_app_number] => 18/055579
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055579
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055579 | OLIGONUCLEOTIDE SYNTHESIZER | Nov 14, 2022 | Pending |
Array
(
[id] => 18349273
[patent_doc_number] => 20230137384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY
[patent_app_type] => utility
[patent_app_number] => 17/982213
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982213
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982213 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | Nov 6, 2022 | Pending |